GLWL Research Inc.
1000 Rue De La Gauchetiere Ouest
Montreal, Quebec H3B4W5
GLWL Research Inc., based in Montreal, Quebec, is a special purpose company created to develop one compound. The project is fully financed by TVM Life Science Innovation I L.P.. To date GLWL-01 has completed non-GLP tox studies and is poised to begin GLP tox studies and file an Investigational New Drug (IND) application in Q1-2015.
If the IND is approved, GLWL-01 will be tested in single ascending dose study in healthy male volunteers and, if appropriate, in a multiple ascending dose study eventually leading to a clinical proof of concept (POC) in T2DM patients. GLWL Research Inc. is funded by TVM Life Science Innovation I L.P. and is led by an experienced management team.